შეჯამება
დიფერენციული დიაგნოზები
ხშირი
- Oral allergy syndrome
- Atopic dermatitis
- Food protein-induced proctocolitis
- Celiac disease
- Lactose intolerance
იშვიათია
- Food-induced anaphylaxis
- Food-dependent exercise-induced anaphylaxis
- Eosinophilic esophagitis
- Food protein-induced enterocolitis
- Congenital sucrase isomaltase deficiency
- Monosodium glutamate (MSG) reactions
- Tyramine reactions
- Sulfite sensitivity
- Galactose-alpha-1,3-galactose (alpha-gal) allergy (tick borne)
კონტრიბუტორები
ავტორები
J. Andrew Bird, MD
Associate Professor
Department of Pediatrics
Division of Allergy and Immunology
University of Texas Southwestern Medical Center
Dallas
TX
გაფრთხილება:
JAB has received grant funding from DBV Technologies, FARE, and Aimmune Therapeutics, and he has received advisory board fees from DBV Technologies, FARE, Pharm-Olam International Ltd, Aimmune Therapeutics, Pfizer Pharmaceuticals, Allergy Therapeutics Ltd, and AllerGenis. He has received speaking fees from Abbott, DBV Technologies, and Aimmune Therapeutics.
A. Wesley Burks, MD

Curnen Distinguished Professor and Chair
Department of Pediatrics
University of North Carolina
Chapel Hill
NC
გაფრთხილება:
AWB receives grant support to his institution from the National Institutes of Health, Food Allergy Research & Education, and Allergen Research Corporation; royalties from UpToDate; consulting honorariums from Aravax, Astella Pharma Global Development, DBV Technologies and N-Fold, LLC, as well as Aimmune Therapeutics, Consortia TX, Inc., Intrommune Therapeutics, and Prota Therapeutics for his service on their respective Scientific Advisory Boards. AWB has consulted for the following companies (which are all now expired): Biomerica, Inc., Evelo Biosciences/Epiva, Genentech, Insys Therapeutics, PPD Development, Sanofi US Services, Valeant Pharmaceuticals North America, LLC, LEK Consulting, LLC, Hycor Biomedical. AWB has received payments for speaking at the Gordon Research Conferences, the Pediatric Allergy and Asthma Meeting, and the American College of Allergy Asthma and Immunology. AWB is a minority stockholder of both Allertein and Mastcell Pharmaceuticals stock. These interests do not directly relate to the article but are being shared for full disclosure. AWB is an author of references cited in this topic.
მადლიერება
Dr J. Andrew Bird and Dr A. Wesley Burks would like to gratefully acknowledge Dr Alison Church, previous contributor to this topic.
გაფრთხილება:
AC declares that she has no competing interests.
რეცენზენტები
Aaron Lerner, MD
Head of Pediatric Gastroenterology and Nutrition Unit
Carmel Medical Center
Haifa
Israel
გაფრთხილება:
AL declares that he has no competing interests.
Roy Gerth van Wijk, MD, PhD
Professor of Allergology
Head of Section of Allergology
Department of Internal Medicine
Erasmus Medical Center
Rotterdam
The Netherlands
გაფრთხილება:
RGvW declares that he has no competing interests.
წყაროები
ძირითადი სტატიები
Shaker MS, Wallace DV, Golden DBK, et al. Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol. 2020 Apr;145(4):1082-123.სრული ტექსტი აბსტრაქტი
Lieberman P, Nicklas RA, Randolph C, et al. Anaphylaxis - a practice parameter update 2015. Ann Allergy Asthma Immunol. 2015 Nov;115(5):341-84. აბსტრაქტი
Golden DBK, Wang J, Waserman S, et al. Anaphylaxis: a 2023 practice parameter update. Ann Allergy Asthma Immunol. 2024 Feb;132(2):124-76.სრული ტექსტი აბსტრაქტი
Rubio-Tapia A, Hill ID, Semrad C, et al. American College of Gastroenterology guidelines update: diagnosis and management of celiac disease. Am J Gastroenterol. 2023 Jan 1;118(1):59-76.სრული ტექსტი აბსტრაქტი
Sampson HA, Aceves S, Bock SA, et al. Food allergy: a practice parameter update-2014. J Allergy Clin Immunol. 2014 Nov;134(5):1016-25.e43.სრული ტექსტი აბსტრაქტი
გამოყენებული სტატიები
ამ თემაში მოხსენიებული წყაროების სრული სია ხელმისაწვდომია მომხმარებლებისთვის, რომლებსაც აქვთ წვდომა BMJ Best Practice-ის ყველა ნაწილზე.
ამ მასალის გამოყენება ექვემდებარება ჩვენს განცხადებას